KAMADA LTD KMDA

Latest FY: 2025 Healthcare Drug Manufacturers - Specialty & Generic
Market Price $7.97
Market Cap $459.76M
P/E Ratio N/A
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↓-98.2% YoY
$180.46M
3-Yr CAGR: 11.7%
Net Income ↑62.3% YoY
$23.47M
Net Margin: 13.0%
Free Cash Flow ↑11.5% YoY
-$8.97M
FCF Yield: -1.95%
EPS (Diluted)
N/A
Basic: N/A
Return on Equity Efficiency
N/A
ROA: 6.2%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (KMDA)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Div / Sh Div Yield Op. Cash Flow Free Cash Flow FCF YoY
FY 2016 $77.5M $21.4M $-5.0M 0.00% $0.1M
FY 2017 $102.8M +32.7% $32.1M $7.2M +243.1% 0.00% $0.0M $-4.1M
FY 2018 $114.5M +11.3% $41.5M $20.3M +183.7% 0.00% $0.1M $-2.8M +31.7%
FY 2019 $127.2M +11.1% $49.7M $23.0M +13.0% 0.00% $0.2M $-2.1M +27.3%
FY 2020 $133.2M +4.8% $47.6M $18.6M -19.2% 0.00% $0.2M $-5.3M -156.6%
FY 2021 $103.6M -22.2% $30.3M $-1.9M -110.2% 0.00% $0.2M $-3.5M +33.7%
FY 2022 $129.3M +24.8% $46.7M $-2.3M -19.8% 0.00% $0.9M $-2.9M +16.3%
FY 2023 $142.5M +10.2% $55.5M $8.4M +473.1% 0.00% $1.2M $-4.6M -57.5%
FY 2024 $10,000.0M +6,916.6% $70.0M $14.5M +71.6% 0.00% $0.6M $-10.1M -119.8%
FY 2025 $180.5M -98.2% $76.4M $23.5M +62.3% 0.00% $0.9M $-9.0M +11.5%
$

Valuation

Market Price $7.97
Market Cap $459.76M
Enterprise Value N/A
P/E Ratio N/A
P/B Ratio N/A
FCF Yield -1.95%
Dividend Yield 0.00%
Shares Outstanding 57,686,100
%

Profitability & Margins

Gross Margin 42.34%
Operating Margin 14.54%
Net Margin 13.00%
Return on Equity (ROE) N/A
Return on Assets (ROA) 6.20%
Asset Turnover 0.48x
Revenue 3-Yr CAGR 11.74%
🛡️

Financial Health & Liquidity

Current Ratio N/A
Cash Ratio N/A
Debt / Equity N/A
Debt / Assets 0.000
Cash & Equivalents N/A
Total Debt N/A
Book Value / Share N/A
💧

Cash Flow Efficiency

Operating Cash Flow $864.00K
Capital Expenditures (CapEx) $9.84M
Free Cash Flow -$8.97M
OCF / Revenue 0.48%
FCF / Revenue -4.97%
FCF 3-Yr CAGR N/A
🏷️

Per Share Metrics

EPS (Diluted) N/A
EPS (Basic) N/A
Dividends / Share N/A
Book Value / Share N/A
EPS YoY Growth N/A
🏛️

Balance Sheet (FY 2025)

Total Assets $378.71M
Total Liabilities N/A
Stockholders' Equity N/A
Current Assets N/A
Current Liabilities $222.00K